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Abstract
Background: The differential expression of virulence genes is often used by microbial pathogens
in adapting to the environment of their host. The differential expression of such sets of genes can
be regulated by RNA polymerase sigma factors. Some sigma factors are differentially expressed,
which can provide a means to identifying other differentially expressed genes such as those whose
expression are controlled by the sigma factor.
Methods: To identify sigma factor-regulated genes, we developed a method, termed I-TRAP, for
the identification of transcriptional regulator activated promoters. The I-TRAP method is based on
the fact that some genes will be differentially expressed in the presence and absence of a
transcriptional regulator. I-TRAP uses a DNA library in a promoter-trap vector that contains two
reporter genes, one to allow the selection of active promoters in the presence of the
transcriptional regulator and a second to allow screening for promoter activity in the absence of
the transcriptional regulator.
Results: To illustrate the development and use of the I-TRAP approach, the construction of the
vectors, host strains, and library necessary to identify SigmaE-regulated genes of Mycobacterium
tuberculosis is described.
Conclusion: The I-TRAP method should be a versatile and useful method for identifying and
characterizing promoter activity under a variety of conditions and in response to various regulatory
proteins. In our study, we isolated 360 clones that may contain plasmids carrying SigmaE-regulated
promoters genes of M. tuberculosis.
Background
The ability of Mycobacterium tuberculosis bacteria to infect
and replicate inside host mononuclear phagocytes is key
to its ability to establish an infection and cause tuberculo-
sis. To elucidate the mechanisms used by tubercle bacilli
to survive in macrophages, researchers at several laborato-
ries are studying mycobacterial genes specifically
expressed during growth in macrophages [1–6]. Among
the genes specifically expressed during intracellular
growth are genes encoding two extracytoplasmic function
sigma factors, SigE (σE) and SigH (σH) [3–5]. Sigma fac-
tors play critical roles in the recognition of promoters by
RNA polymerase. In several systems, individual sigma fac-
tors are known to regulate the differential expression of
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sets of genes involved in specific processes, such as genes
involved in the heat-shock response or those required for
sporulation in Bacillus subtilis [7,8].
Identifying a differentially expressed sigma factor can pro-
vide a means to identifying other differentially expressed
genes – genes whose expression are controlled by the
sigma factor. To identify sigma factor-regulated genes, we
developed a method, termed I-TRAP, for the identification
of transcriptional regulator activated promoters. I-TRAP
takes advantage of the fact that some genes will be differ-
entially expressed in the presence and absence of a tran-
scription regulatory protein. To identify transcription
factor-dependent promoters, a genomic DNA library is
generated in a promoter-trap plasmid containing two
reporter genes. The library is transformed into strain
expressing the transcription factor, and recipients with
plasmids containing an active promoter are selected by
virtue of expression of one of the reporter genes. The plas-
mids are recovered and transformed into a strain that does
not express the transcription factor. Promoters dependent
on the expression of the regulator are differentiated from
other promoters by screening for lack of reporter activity
in bacteria not expressing the regulatory protein. To illus-
trate the development and use of the I-TRAP approach, we
describe here the construction of the vectors, host strains,
and library necessary to identify σE-regulated genes of M.
tuberculosis.
Methods
Bacterial strains and growth condition
Bacterial strains are listed in Table 1. Escherichia coli
strains were grown in Luria Broth (LB) or on LB agar.
Mycobacterium smegmatis LR222 strains were grown in
Middlebrook 7H9 broth supplemented with 10% albu-
min-dextrose-catalase (ADC, v/v, Difco Laboratories,
Detroit, MI) and 0.05% Tween 80 (v/v, Sigma, St. Louis,
MO) at 37°C, with agitation on a rotating platform (100
rpm), or were grown on trypticase soy agar (TSA) plates.
M. tuberculosis H37Rv TMC102 cultures were grown in
Middlebrook 7H9 broth supplemented with ADC and
0.05% Tween 80 at 37°C in 250 ml nephelometer flasks
on a rotating platform (60 rpm) or were grown on Mid-
dlebrook 7H10 plates with 10% oleic acid-albumin-dex-
Table 1: Bacterial strains and plasmids. Plasmid pAWS2 was provided by Rosalind Van Landingham, pBluescript-int was provided by 
Bonnie Plikaytis, and pUS267 was provided by Jeremy Dale
Strains Relevant Characteristics Source/Reference
Electromax DH5α Cloning host Invitrogen
M. smegmatis LR222 Cloning host [20]
M. smegmatis::SEint.2 constitutively expresses M. tuberculosis sigE gene This study
M. smegmatis∆sigE sigE knockout mutant This study
M. tuberculosis H37Rv TMC102 Virulent laboratory strain [21]
Plasmids
pAWS2 Source of the lacZ gene R. Van Landingham
pBluescript-int Source of integrase gene, int B. Plikaytis
pCL5 Backbone for pCL8 [9]
pCL8 Source of the rpsL promoter This study
pCRScript SK (+) Vector with multiple cloning site Stratagene
pMV261 Source of the hsp60 promoter and OriM [22]
pPICZalphaC Source of bleomycin resistance gene, ble Invitrogen
pPR27 Source of gentamicin resistance gene, aacC1 [23]
pSE.1 pUC19 with promoterless aph and xylE genes This study
pSE.2 pSE.1 with the hyg gene This study
pSE.3 pSE.2 with the OriM This study
pSE.4 promoter-trap vector This study
pSEint.1 Integrating plasmid containing the ble gene This study
pSEint.2 Integrating plasmid, constitutive M. tuberculosis sigE expression This study
pSEKO.1 5' region of the M. smegmatis sigE gene This study
pSEKO.2 pSEKO.1 with 3' end of M. smegmatis sigE gene This study
pSEKO.3 pSEKO.2 with the aacC1 gene This study
pSEKO.4 Suicide plasmid with interrupted M. smegmatis sigE gene This study
pT7Blue Blunt cloning vector This study
pTKMX97 Source of the xylE gene [10]
pUC19 Vector with multiple cloning site Amersham Biosciences
pUC4-KIXX Source of aph gene Amersham Biosciences
pUS267 Source of hygromycin resistance gene, hyg J. DaleBMC Infectious Diseases 2003, 3 http://www.biomedcentral.com/1471-2334/3/15
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trose-catalase (OADC, Difco). For selection of E. coli
bacteria, drugs were incorporated into the medium at the
following concentrations: hygromycin (Invitrogen,
Carlsbad, CA), 200 µg/m; kanamycin (Sigma), 25 µg/ml;
zeocin (Invitrogen), 25 µg/ml; and gentamicin (Invitro-
gen), 20 µg/ml. For selection of M. smegmatis bacteria,
drugs were incorporated into medium at the following
concentrations: hygromycin (Invitrogen), 50 µg/ml; kan-
amycin (Sigma), 50 µg/ml; zeocin (Invitrogen), 50 µg/ml;
and gentamicin (Invitrogen), 5 µg/ml.
Plasmids
Plasmids used in this study, along with their key features
and sources, are listed in Table 1. Two of the source plas-
mids, pCL8 and pAWS2, were constructed as part of
unpublished studies. pCL8 is a derivative of pCL5 [9] and
contains the luciferase (luc) gene from pT3/T7LUC (Clon-
tech, Palo Alto, CA), the mycobacteriophage L5 int gene,
the kanamycin-resistance gene (aph) from pUC4-KIXX
(Amersham Biosciences, Piscataway, NJ), and the PrpsL-
xylE  cassette from pTKmx97 in which the BamHI site
between the M. smegmatis rpsL promoter and the xylE gene
in pTKmx97 [10] was changed into a KpnI site by site-
directed PCR mutagenesis. pAWS.2 is a promoter-trap
plasmid containing a promoterless lacZ  gene isolated
from λgt11 in which the EcoRI site in the 3' end of the lacZ
gene was removed by site-directed polymerase-chain-reac-
tion (PCR) mutagenesis (personal communication R. Van
Landingham).
Construction of pSEint.2
1) The ble gene was PCR amplified from pPICZalphaC as
a 375-bp fragment using primers Ble-N and Ble-C; the
amplicon was blunt-ended and ligated into the blunt-
cloning site of pT7Blue to generate pT7Blue-bleA. 2) The
ble gene was recovered as a 382-bp BamHI fragment from
pT7Blue-bleA and cloned into BamHI cleaved pMV261 to
generate pMV261-ble. 3) A 1077-bp Phsp60-ble cassette was
PCR amplified from pMV261-ble using primers 981816
and 981819 and blunt cloned into pT7Blue to generate
pT7Blue-bleB. 4) The Phsp60-ble  cassette was recovered
from pT7Blue-bleB by XbaI digest and cloned into the
XbaI site of a pBluescript KS+ based plasmid that had the
mycobacteriophage L5 integrase gene cloned into the
EcoRI site to generate pSEint.1. 5) The M. tuberculosis sigE
gene was PCR amplified from H37Rv genomic DNA using
primer 987917 and primer 987916 (which contains a
BamHI site), digested with BamHI, and cloned into
pMV261 digested with HpaI and BamHI. 6) The Phsp60-sigE
cassette was PCR amplified using primers 981816 and
981819 and cloned into pT7Blue to generate pT7Blue-
Phsp60-sigE. 7) The Phsp60-sigE cassette was recovered from
pT7Blue-Phsp60-sigE by digestion KpnI and cloned into the
KpnI site of pSEint.1 to generate pSEint.2.
Construction of pSEKO.4
1) A 757-bp fragment containing 246 bp of the 3' end of
the M. smegmatis sigE gene and 511 bp of the 5' end of the
adjacent  ORF1  gene was PCR amplified using primer
7208 (which contains a HpaI restriction site) and primer
7209 and cloned into the EcoRV blunt-cloning site of
pT7Blue to generate pSEKO.1. 2) A 760-bp fragment con-
taining 526 bp of the 5' region of the M. smegmatis sigE
gene and 234 bp of the region upstream was PCR ampli-
fied using primer 7206 and primer 7207 (which contains
a HpaI restriction site), digested with HpaI, and cloned
into the HpaI site of pSEKO.1 to generate pSEKO.2. These
steps resulted in a 2-bp deletion of the sigE gene. 3) The
gentamicin-resistance gene (aacC1) was PCR-amplified
from pPR27 as a 1270-bp fragment using primer 7204
and primer 7205 (both of which contain HpaI restriction
sites), digested with HpaI, and cloned into the HpaI site
located between the two fragments of the sigE gene in
pSEKO.2 to generate pSEKO3. 4) The rpsL promoter was
isolated from pCL8 as a BamHI-KpnI fragment and cloned
into BamHI-KpnI digested pAWS2 upstream of the lacZ
gene. 5) The PrpsL-lacZ  cassette was removed from this
recombinant by BamHI and EcoRI digestion and cloned
into BamHI and EcoRI digested pBluescript SK+. 6) The
PrpsL-lacZ cassette was isolated from this subclone as a Hin-
dIII fragment, and the ends of the fragment were blunt-
ended using the Perfectly Blunt Cloning Kit (Novagen,
Madison, WI) and cloned into the ScaI site of pSEKO.3 to
generate pSEKO.4.
Construction of pSE.4
1) A promoterless TN5 aph gene was PCR amplified from
pUC4-KIXX as an 850-bp fragment using primers 1915
and 1916, and a promoterless xylE gene was PCR
amplified from pTKMX97 as a 935-bp fragment using
primers 1917 and 1918. Primers 1916 and 1917 have 20
nucleotides of complementary sequence so that the two
PCR products can anneal. The two PCR products were
mixed, allowed to anneal, and amplified using two prim-
ers, one (1915) complementary to the 5' end of the aph
gene and a second (1918) complementary to the 3' end of
xylE to produce a 1785-bp fragment. The amplified
annealed fragment was gel purified and cloned into the
SmaI site of pUC19 to generate pSE.1. 2) The hygromycin
B-resistance gene (hyg) was recovered from pUS267 by
HindIII digestion and cloned into the HindIII site of
pSE.1 to generate pSE.2. 3) A 1903-bp fragment contain-
ing oriM was recovered from pMV261 by digestion with
NotI and MluI, gel purified, blunt ended using the Per-
fectly Blunt Cloning Kit (Novagen), and ligated into pSE.2
digested with SspI to generate pSE.3. 4) An amplicon con-
taining the E. coli rRNA transcriptional terminator was
PCR amplified from pCL5 using primers 5077 and 5078
(which contain XbaI sites), digested with XbaI, and ligated
into XbaI digested pSE.3 to generate pSE.4. Function ofBMC Infectious Diseases 2003, 3 http://www.biomedcentral.com/1471-2334/3/15
Page 4 of 10
(page number not for citation purposes)
the terminator was determined by patching hygromycin
B-resistant transformants LB medium containing
kanamycin.
DNA manipulations and DNA sequencing
Restriction enzyme reactions were performed as recom-
mended by the manufacturer (Invitrogen). Wizard Plus
Minipreps DNA Purification System (Promega, Madison,
WI) was used to isolate plasmid DNA from E. coli bacteria
and from M. smegmatis bacteria as previously described
[11]. Phosphatase reactions using Calf Intestinal Alkaline
Phosphatase (Invitrogen) and ligation reactions using T4
DNA Ligase (Invitrogen) were carried out according to
manufacturer's directions. Sequencing reactions were car-
ried out using the Big Dye Terminator Cycle Sequencing
Ready Reaction Kit as recommended by manufacturer
(Applied Biosystems). Sequence reactions were analyzed
using an ABI 373 DNA sequencer and sequence data were
assembled using SeqEd 675 DNA Sequence Editor, ver-
sion 1.0.3 (Applied Biosystems).
Genomic DNA isolation
M. smegmatis genomic DNA was purified by a modifica-
tion of the glass-bead lysis method as previously
described [12]. M. tuberculosis genomic DNA was iso-
lated as previously described [13]. DNA concentration
was estimated using a GeneQuant II apparatus (Amer-
sham Biosciences).
Polymerase chain reaction
The primers used in this study are listed in Table 2. Prim-
ers were synthesized on a 381A DNA synthesizer (Applied
Biosystems, Foster City, CA) at the Biotechnology Core
Facility, National Center for Infectious Diseases, Centers
for Disease Control and Prevention. 50 µl amplification
reactions contained 100–200 ng DNA template and 45 µl
of a reaction mix (200 µM each, deoxynucleotide triphos-
phates; 1.0 µM each primer; 1.25 U Taq polymerase; 10
mM Tris hydrochloride (pH 8.3); 50 mM KCl; 1.5 mM
MgCl2; 0.01% gelatin). Samples were amplified for 30
cycles in a GeneAmp PCR system 2400 thermocycler
(Applied Biosystems) with a three-step cycle of
Table 2: Oligonucleotide primers. Underlined bases are restriction sites relevant to the construction. MS: Mycobacterium smegmatis; 
MTB: Mycobacterium tuberculosis; Phsp60: promoter for the M. tuberculosis hsp60 gene. PrpsL: promoter for the M. smegmatis rpsL gene
Primer Designation Sequence 5' to 3' Gene Amplified
Ble-N ataaat ggatccaatggccaagttgaccagt ble
Ble-C aaataa ggatcctcagtcctgctcctcggc ble
TN9-5R cagggcaccggacaggtcggtc aph
981816 atgtacgtggcgaactccgttgta Phsp60
981819 gatgatatatttttatcttgtgca Phsp60
987916 gggcccaa ggatccaatggaactcctcggcggaccc MTBsigE
987917 agcgaactgggttgacgtgaactgc MTBsigE
106777 tggaactcctcggcggacc MTBsigE
106778 tgacgtgaactgcgcactcg MTBsigE
7208 tgcga gttaaccgaaccccgagcagatctacgacg MSsigE
7209 gcatctctagaagccgatcgcgtgtcggcgtc MS sigE
7206 gcatcaagctttgctctagatcggagatcgaccgtttctg MSsigE
7207 tcggt gttaaccctcggcgggcacgcggtcg MSsigE
7204 cgtga gttaacctcgcgcagcgtgggtgc aacC1
7205 gaccg gttaacggcgttgtgacaatttaccgaac aacC1
7997 cctcgacatggtgcgccg MSsigE
7998 caggcgcgaatcgtggtag MSsigE
7999 gccgtctgcccaattgcag MTBsigE
1915 gatca ggatccgatcaagagac aph
1916 gcattacacttttgttcatttcgaaccccagagtcccgctc aph
1917 agcgggactctggggttcgaaatgaacaaaggtgtaatgcg xylE
1918 ccgggccggaccatcaggtcagc xylE
5077 cgtgc tctagagcgagagtagggaactgc rRNA
5078 CGTCGT CTAGAGACGACAGGAAGAGTTTGTAG rRNA
47 CGGAGGAATCACTTCGCAATG hsp60
39A GGAGTTGAAGGCGATCTGCTT hsp60
MA1 GTGCCCGCACGCCG GGTACCATGAACTATGAGG PrpsL
MA2 CCTCATAGTTCAT GGTACCCGGCGTGCGGGCAC PrpsL
TK97L TCGA AAGCTTCGTCGCGGTCGGCCC PrpsLBMC Infectious Diseases 2003, 3 http://www.biomedcentral.com/1471-2334/3/15
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denaturation for 30 s at 94°C, annealing for 30 s at 55°C
to 70°C (optimized for each primer pair), and extension
for 1 min at 72°C. Amplification products were analyzed
by electrophoresis through 0.8 to 2.0% agarose-TBE gel
and visualized by ethidium-bromide staining.
Electroporation
Electrocompetent M. smegmatis bacteria and E. coli bacte-
ria (Biorad) were produced and DNA was electroporated
into these bacteria as previously described [14,15].
Selection of active promoters
Electrocompetent  M. smegmatis LR222::SEint.2 bacteria
were electroporated with 5 µg of the library plasmid DNA,
and recipients were plated on TSA with kanamycin (50
µg/ml). After incubation at 37°C for 3 days, colonies were
pooled and collected by flooding plates with 2 ml Middle-
brook 7H9 broth and scraping the colonies off the plate.
Plasmid DNA was harvested from the transformants, eth-
anol precipitated, and resuspended in water.
Screening to identify σE-dependent promoters
Electrocompetent  M. smegmatis LR222∆sigE  cells were
electroporated with approximately 1 µg plasmid DNA
from the pool of kanamycin-resistant transformants, and
recipients were plated on TSA with hygromycin B (50 µg/
ml). After incubation at 37°C for 3 days, colonies were
chilled for 2 h at 4°C. Chilled colonies were sprayed with
0.5 M catechol (Sigma) in 0.05 mM potassium phosphate
buffer pH 7.4.
Results
Experimental strategy
The basic I-TRAP approach (Figure 1) uses a genomic
DNA library in a plasmid vector containing a promoter-
less 'operon' with two reporter genes. One reporter gene,
the  aph  gene which confers resistance to kanamycin,
allows for selection of active promoters and a second
reporter gene, the xylE gene which encodes catechol 2,3
dioxygenase, allows for screening for loss of promoter
activity. In the first step of the I-TRAP approach, the
recombinant plasmid library is transformed into bacteria
expressing the transcriptional regulator. Transformants
containing plasmids with active promoters are isolated by
selection on kanamycin-containing media. A subset of the
active promoters will be those whose expression depends
on the transcriptional regulator. To differentiate between
promoters dependent on the regulator and other promot-
ers, plasmid DNA from a pool of the kanamycin-resistant
transformants is transformed into bacteria that do not
express the transcriptional regulator. The hygromycin B-
resistant transformants are screened for XylE expression
by spraying colonies with catechol. Yellow colonies arise
from bacteria that contain a plasmid with a transcription-
ally active promoter. White colonies arise from bacteria
that contain a plasmid with a promoter that is inactive in
the absence of the transcriptional regulator.
To develop the I-TRAP method for identifying M. tubercu-
losis promoters dependent on the expression of σE, a strain
of M. smegmatis over-expressing the M. tuberculosis σE, a σE
mutant strain of M. smegmatis, and a M. tuberculosis pro-
moter-trap library were created.
Construction of σE-over-expressing strain of M. 
smegmatis
The σE-over-expressing strain of M. smegmatis was made
by transforming M. smegmatis LR222 bacteria with
pSEint.2 (Figure 2). The pSEint.2 plasmid contains an oriE
for plasmid replication in E. coli, the mycobacteriophage
L5 integrase and attP site to allow integration into the M.
smegmatis chromosome, two selectable genes, ble (bleo-
mycin or zeocin resistance) and amp (ampicillin resist-
ance), and the M. tuberculosis RV1221 ORF cloned
downstream of the M. tuberculosis hsp60 promoter. In this
strain, the M. tuberculosis sigE gene is maintained in a sin-
gle copy in the genome and is constitutively expressed
from the hsp60  promoter. This strain is designated M.
smegmatis LR222::SEint.2 (Table 1).
Construction of sigE mutant strain of M. smegmatis
The suicide plasmid pSEKO.4 (Figure 3) was constructed
to interrupt the M. smegmatis sigE gene by gene
replacement [14]. pSEKO.4 contains the M. smegmatis sigE
gene interrupted with a gentamicin-resistance gene and
the lacZ gene. The pSEKO.4 DNA (1 µg) was UV-irradiated
in a UV Stratalinker 1800 (Stratagene) at 100 mJ cm-2 and
electroporated into M. smegmatis cells. Following out-
growth at 37°C for 4 h, transformants were recovered by
plating on TSA containing gentamicin and X-Gal. 24
white transformants were analyzed by PCR using primers
(7997 and 7998) that bind to the sigE gene on either side
of the aacC1 gene (Table 2). Of the 24 transformants, 11
had the M. smegmatis sigE gene disrupted by aacC1, 9 had
only a single recombination event, and 4 only had a wild-
type copy of sigE (data not shown). One transformant was
chosen as the M. smegmatis sigE mutant strain and desig-
nated LR222∆ sigE (Table 1).
Construction of a library in the promoter-trap plasmid
pSE.4 (Figure 4) is a promoter-trap plasmid containing a
promoterless aph gene and xylE gene, an E. coli rRNA tran-
scriptional terminator upstream of the reporter genes, an
oriM for plasmid replication in M. smegmatis, an oriE for
plasmid replication in E. coli, and a hyg gene for selection
in E. coli and M. smegmatis bacteria. The plasmid contains
a unique BamHI site upstream of the promoterless
reporter operon for cloning of potential promoters. To
generate fragments of the M. tuberculosis H37Rv genome,
~3.0 µg of genomic DNA was digested with 1 U Sau3AI inBMC Infectious Diseases 2003, 3 http://www.biomedcentral.com/1471-2334/3/15
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Schematic of I-TRAP approach Figure 1
Schematic of I-TRAP approach.BMC Infectious Diseases 2003, 3 http://www.biomedcentral.com/1471-2334/3/15
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20 µl total volume for 2 min at 37°C and the reaction
stopped by heating at 65°C for 10 min. This generated
fragments between 100 and ~6,000 bp (data not shown).
Sau3AI was removed from the reaction by phenol-chloro-
form extraction. DNA was ethanol precipitated and resus-
pended in 20 µl Tris buffer pH 7.4. Approximately 470 ng
digested genomic DNA was ligated with ~200 ng pSE.4
DNA that had been digested with BamHI and phos-
phatased. DNA was ethanol precipitated from the ligation
reaction and resuspended in water; 200 ng DNA was
electroporated into Electromax DH5α cells. Recipient bac-
teria were spread on LB agar containing hygromycin B.
After overnight incubation at 37°C, 50 colonies were
selected at random, plasmid DNA was harvested, and
genomic DNA inserts were sequenced using primer TN5-
9R (Table 2). All plasmids contained a unique M. tubercu-
losis  DNA segment and had an average insert size of
approximately 200 bp (data not shown).
To generate a library of recombinant plasmids, 200 ng of
the ligated sample were electroporated into Electromax
DH5α cells. The entire mixture was plated on 117 150
mm LB agar plates containing hygromycin B. About
117,000 transformants were collected and pooled by
flooding each plate with 2 ml LB and scraping the colo-
nies off the plate. Plasmid DNA was harvested from the
pooled  E. coli transformants, ethanol precipitated, and
resuspended in water.
Promoter selection and scoring
To recover plasmids containing active promoters, the plas-
mid library DNA was electroporated into M. smegmatis
LR222::SEint.2 bacteria, which constitutively express the
M. tuberculosis sigE gene. To determine the proportion of
active promoters in the library, a portion of the transfor-
mation mixture was spread on medium containing hygro-
mycin B (all recipients), and a portion was spread on
medium containing kanamycin (recipients with an active
promoter). 1.93 × 106  hygromycin B-resistant colony
forming units (CFUs) /ml and 3.75 × 104 kanamycin-
resistant CFU/ml were recovered; therefore, approxi-
mately 1.9% of transformants contained an active pro-
Map of pSEint.2 Figure 2
Map of pSEint.2. pSEint.2 contains an oriE for plasmid repli-
cation in E. coli, the mycobacteriophage L5 integrase (int) and 
attP to allow integration into the M. smegmatis chromosome, 
a ble gene (bleomycin resistance) for selection in mycobacte-
ria, an amp gene (ampicillin resistance) for selection in E. coli, 
and the M. tuberculosis sigE gene under the control of the 
constitutively expressed hsp60 promoter. Arrowheads indi-
cate direction of transcription.
Map of pSEKO.4 Figure 3
Map of pSEKO.4 pSEKO.4 contains the M. smegmatis sigE 
gene interrupted with a gentamicin-resistance gene, aac1, the 
lacZ gene for use as a screen against single recombination 
events, and an oriE for plasmid replication in E. coli. Arrow-
heads indicate direction of transcription. The construction of 
the mutated sigE gene resulted in an insertion of the aac1 
cassette and a 2-bp deletion of the sigE gene at the site of 
insertion.BMC Infectious Diseases 2003, 3 http://www.biomedcentral.com/1471-2334/3/15
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moter fragment. When the initial pool of kanamycin-
resistant colonies sprayed with catechol, the colonies were
light to dark yellow indicating a wide range of XylE
activity.
To differentiate between σE-dependent and -independent
promoters, approximately 40,000 kanamycin-resistant
transformants were pooled, and plasmid DNA was iso-
lated and electroporated into M. smegmatis LR222::∆ sigE
bacteria, in which the wild type copy of the sigE gene had
been disrupted with the gentamicin-resistance gene.
Transformants were plated on hygromycin B and assayed
for catechol 2,3 dioxygenase activity by spraying colonies
with 0.5 M catechol. About 20,000 colonies were sprayed
with catechol, and a range of color intensity from white to
bright yellow was observed. A total of 360 white and light
yellow colonies were recovered. Overall, about 1.8% of
hygromycin B-resistant colonies were white or light
yellow.
To confirm the phenotypes of plasmids recovered in this
two-step procedure, plasmids were recovered from 18
white colonies and individually transformed into M.
smegmatis LR222::SEint.2 (SigE-expressing) and M. smeg-
matis LR222::∆ sigE bacteria. All 18 plasmids generated
only white colonies when transformed into the σE-mutant
strain. However, although all 18 plasmids generated yel-
low colonies when transformed into σE-expressing bacte-
ria, some plasmids produced a mixture of white and
yellow colonies. These white colonies were consistently
white on retesting and their plasmids usually contained
deletions that removed the cloned M. tuberculosis
sequence. Replating of the yellow colonies produced a
mixture of white and yellow colonies, suggesting that the
expression of the xylE or aph gene in the SigE-expressing
strain may be detrimental to the cell and may lead to plas-
mid instability.
A preliminary analysis of the sequences of the inserts in
the 18 clones identified 6 inserts that had matches with
the SigE consensus sequence [6]. Interestingly, none of
these genes were identified as being SigE-induced genes in
microarray studies [6], although the expression of one of
the genes, Rv3223c (sigH), is thought to be SigE-regulated
[5].
Discussion
A key feature of the I-TRAP method is that it allows two
degrees of promoter analysis, i.e., with and without a tran-
scriptional regulator. The first step allows selection of all
active promoters under one condition, and the second
step sorts promoters by activity dependent on a second
condition. In the study reported here, we used this
method to identify potential σE-induced genes. The basic
I-TRAP approach might also be used to identify promoters
repressed by a particular protein. The transformation steps
are reversed so that the promoters are selected in the
mutant background first (i.e., no repressor) and then
screened for loss of activity in the presence of the repressor
protein.
The I-TRAP method might also be used to characterize
promoter activity in two environmental conditions in a
manner similar to the IVET approach [16]. This is useful
because, in some cases, the factor necessary for transcrip-
tional activation during a particular environmental condi-
tion is unknown. In this case, after exposing bacteria
containing the recombinant library to an environmental
condition (e.g., a heat shock or acid shock or growth in
medium A), antibiotics could be added to the medium to
kill any bacteria that had not expressed the antibiotic
resistance reporter gene during the exposure. For myco-
bacteria, a two-hour treatment with kanamycin would be
sufficient to kill bacteria that had not expressed the kan-
amycin-resistance gene during the stress. The resistant
bacteria would then be grown in a second medium or in
the absence of a stress, and colonies scored for lack of pro-
moter activity in the second condition by expression of
the xylE reporter gene. White colonies would contain a
plasmid with a promoter that is active only during the first
Map of pSE.4 Figure 4
Map of pSE.4. pSE.4 is a promoter-trap plasmid containing 
a promoterless aph gene and xylE gene, an E. coli rRNA tran-
scriptional terminator cloned upstream of the promoterless 
aph and xylE genes, a unique BamHI cloning site, an oriM for 
plasmid replication in mycobacteria, an oriE for plasmid repli-
cation in E. coli, and a hyg gene for selection in E. coli and M. 
smegmatis bacteria. Arrowheads indicate direction of 
transcription.BMC Infectious Diseases 2003, 3 http://www.biomedcentral.com/1471-2334/3/15
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condition. Using I-TRAP for this purpose may provide a
means to identify promoters dependent on any of several
regulatory proteins that may be active during the stress
and to obtain a global overview of gene expression during
the stress.
In the I-TRAP method, the recipient strain can be the
native bacterium or a surrogate host. We used M. smegma-
tis as the host because it grows much more rapidly than
does M. tuberculosis (generation time of 3 hrs vs. 24 hrs),
does not require BSL-3 facilities, and is more easily
manipulated genetically than M. tuberculosis. One possible
advantage of using a surrogate host is that studies could be
focused on one particular regulator which might avoid
complications due to other regulatory proteins in the cell
that may be able to recognize promoters in the library. Of
course, the surrogate host must not have a regulatory pro-
tein that recognizes the same promoters as the regulator
being studied. In our studies, the M. smegmatis σE protein
has 92% homology with the M. tuberculosis σE protein
[17]. While this suggests that the M. tuberculosis σE protein
should be able to interact properly with the M. smegmatis
RNA polymerase, it also suggests that the M. smegmatis σE
homolog might be able to recognize M. tuberculosis σE-
dependent promoters. Because of this, we constructed an
M. smegmatis host strain that lacked any functional σE pro-
tein.
An assumption of the I-TRAP approach is that the
sequences cloned in the plasmids will be recognized by
transcriptional regulatory proteins in the same manner as
the intact sequences in the genome. The cloning process
might generate false-positive or false-negative results
because of the cloned sequences being recognized out of
the context of the surrounding genomic sequences.
Another assumption of the I-TRAP approach is that over-
expression of a transcriptional regulator will be sufficient
to induce gene expression from its regulated promoters.
This suggests that proteins, such as PhoP, that require acti-
vation to promote transcription may not be approachable
with this method unless the over-expressed regulatory
protein can also be activated. Also, certain regulatory pro-
teins may not be suitable for study in a surrogate host bac-
terium [18]. For proteins that require the presence of
additional factors, such as σN, or interaction with host
proteins to be active, such as σE with RNA polymerase, use
of the native bacterium or closely related surrogate host
may be required to ensure the presence of the necessary
interacting proteins [19]. Some of these additional factors,
however, may only be expressed or active under a particu-
lar growth condition and therefore may also need to be
conditionally expressed along with the transcription fac-
tor. Promoters that require both a positive transcription
regulator and the absence of a repressor protein may be
missed because expressing the positive transcription fac-
tor alone may not be sufficient to induce transcription at
such promoters. Another limitation of the I-TRAP method
is that some transcription factors may not be stably main-
tained in the bacterium or may be lethal to the bacterium
when over-expressed. To avoid this problem, an inducible
promoter could be used to promote transcription of the
gene encoding the transcription factor.
Another possible complication of this approach is that
expressing a foreign protein may turn on the stress
response of the host bacterium. Transcription factors
mediating the stress response to the expressed foreign
protein may be able to recognize promoters within the
library and promote transcription of the reporter genes,
thus producing the false positives in the two-step screen.
Because the first step of the I-TRAP method involves selec-
tion for active promoters, one could easily begin with a
library containing recombinants representing all possible
promoters in a bacterial genome. Unfortunately, the
recombinant DNA library used in this study contained
only ~65% of the genome in the correct orientation
upstream of the reporter genes, which will limit the
number of different promoters we can recover using this
library. For the screening step, we used the xylE  gene
because catechol 2,3 dioxygenase activity is easily meas-
ured by spraying colonies with catechol and the amount
of color produced is a rough measure of promoter activity
[10]. In our screen, white, pale yellow, and bright yellow
colonies were observed, indicating a wide range of pro-
moter activity. Pale yellow colonies may represent weak
σE-independent promoters or promoters that are recog-
nized by another sigma factor in addition to σE, providing
a low level of constitutive expression. These possibilities
could be distinguished by transformation of plasmids
from individual clones into the σE-over-expressing strain
and directly comparing of XylE activity in the presence
and absence of σE. Unfortunately, it appears that expres-
sion of XylE in M. smegmatis may be detrimental and may
lead to plasmid instability and loss of the inserted DNA.
This raises the possibility that some white colonies may
arise in the second step of I-TRAP by loss of a promoter
fragment from a plasmid recovered in the first step. None-
theless, the I-TRAP method should greatly enrich for pro-
moters with the desired activities. As is generally true for
genetic screens, it is essential to study any identified pro-
moters in their native state to understand the regulation of
their expression.
Conclusions
The I-TRAP method is a versatile and useful method for
characterizing promoter activity under a variety of condi-
tions and in response to various regulatory proteins. In
our study, we isolated 360 clones that may contain plas-Publish with BioMed Central    and   every 
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mids carrying SigE-regulated promoters genes of M. tuber-
culosis. The analysis of these clones will be reported
elsewhere.
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